Viewing Study NCT02431767


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-01-07 @ 9:57 AM
Study NCT ID: NCT02431767
Status: COMPLETED
Last Update Posted: 2021-10-15
First Post: 2015-04-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating the Safety and Immunogenicity of PENNVAX®-GP DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected Adults
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module